Sarah Bandy



San Antonio, TX

Quote from Foundation- ---

Areas of Expertise

  • Health Outcomes Research
  • Real-world data analysis
  • Statistics


Sarah Bandy is the Visiting Scientest with AESARA. She currently works directly with staff in the Evidence Institute and the Strategic Consulting Group. Sarah received her PharmD Degree from the University of Texas at Austin College of Pharmacy and the Univeristy of Texas Health at San Antonio. During pharmacy school she was a research assistant within the colleges division of pharmacotherapy, and worked on a variety of projects involving analysis of rapid diagnostic technology to reduce mortality in bloodstream infections. Sarah recently completed a two-year post-graduate pharmacotherapy residency and is currenty obtaining her PhD in Pharmaceutical Science, where her dissertation research focuses on outcomes of metformin and vaccines using national claims databases.

Key accomplishments

Since graduating from The University of Texas at Austin College of Pharmacy, Sarah has received several scholarships and awards based on her research and service, such as the Leo F. and Ann Godley Residency Fellowship Award and the Robert L. Talbert Jr Endowment for Excellence in Pharmacotherapy Scholarship. Additionally, she has co-authored two manuscripts in addition to her research.

Key publications

  • Bandy S, Jackson CB, Black CA, Godinez W, Gawrys G, Lee GC. Molecular rapid diagnostics improves time to effective therapy and survival in patients with vancomycin-resistant Enterococcus bloodstream infections. 2023; 12(2):210.
  • Lee G, Alvaro M, Hinojosa C, Benavides R, Winter C, Anderson A, Chen CJ, Borsa N, Hastings G, Black C, Bandy S, Shaffer A, Restrepo M, Ahuja S. Metformin attenuates inflammatory responses and enhances antibody production in acute pneumonia model of Streptococcus pneumoniae. Front Aging. 2022; 3:736835


  • BS, Biochemistry Texas A&M University
  • PharmD, The University of Texas at Austin, College of Pharmacy

Contact us

Fill out the form below, and we will be in touch shortly.